Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth J Rahn

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 1, 2009
Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedsideElizabeth J Rahn, Andrea G Hohmann
Therapeutic Advances in Musculoskeletal Disease|October 1, 2019
Glucocorticoid-induced osteoporosis: from clinical trials to clinical practiceGiovanni Adami, Elizabeth J Rahn, Kenneth G Saag
Neurobiology of Learning and Memory|June 26, 2013
Cellular, molecular, and epigenetic mechanisms in non-associative conditioning: implications for pain and memoryElizabeth J Rahn, Mikael C Guzman-Karlsson, J David Sweatt
Frontiers in Psychology|November 12, 2015
Do long delay conditioned stimuli develop inhibitory properties?Martha Escobar, W T Suits, Elizabeth J Rahn, et al.
Expert Opinion on Drug Safety|August 1, 2020
Cardiovascular safety risks associated with gout treatmentsGiovanna Rosas, Angelo Gaffo, Elizabeth J Rahn, et al.
The AAPS Journal|February 4, 2010
Antinociceptive effects of racemic AM1241 and its chirally synthesized enantiomers: lack of dependence upon opioid receptor activationElizabeth J Rahn, Alexander M Zvonok, Alexandros Makriyannis, et al.
Biology of Sex Differences|March 4, 2014
Sex differences in a mouse model of multiple sclerosis: neuropathic pain behavior in females but not males and protection from neurological deficits during proestrusElizabeth J Rahn, Tommaso Iannitti, Renee R Donahue, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 31, 2008
Selective activation of cannabinoid CB2 receptors suppresses neuropathic nociception induced by treatment with the chemotherapeutic agent paclitaxel in ratsElizabeth J Rahn, Alexander M Zvonok, Ganesh A Thakur, et al.
Pharmacology, Biochemistry, and Behavior|March 9, 2011
Pharmacological characterization of AM1710, a putative cannabinoid CB2 agonist from the cannabilactone class: antinociception without central nervous system side-effectsElizabeth J Rahn, Ganesh A Thakur, Jodi Anne T Wood, et al.
Research in Social & Administrative Pharmacy : RSAP|October 4, 2020
Use of path modeling to inform a clinical decision support application to encourage osteoporosis medication useMichael J Miller, Tzuchen Jou, Maria I Danila, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 1, 2009
Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedsideElizabeth J Rahn, Andrea G Hohmann
Therapeutic Advances in Musculoskeletal Disease|October 1, 2019
Glucocorticoid-induced osteoporosis: from clinical trials to clinical practiceGiovanni Adami, Elizabeth J Rahn, Kenneth G Saag
Neurobiology of Learning and Memory|June 26, 2013
Cellular, molecular, and epigenetic mechanisms in non-associative conditioning: implications for pain and memoryElizabeth J Rahn, Mikael C Guzman-Karlsson, J David Sweatt
Frontiers in Psychology|November 12, 2015
Do long delay conditioned stimuli develop inhibitory properties?Martha Escobar, W T Suits, Elizabeth J Rahn, et al.
Expert Opinion on Drug Safety|August 1, 2020
Cardiovascular safety risks associated with gout treatmentsGiovanna Rosas, Angelo Gaffo, Elizabeth J Rahn, et al.
The AAPS Journal|February 4, 2010
Antinociceptive effects of racemic AM1241 and its chirally synthesized enantiomers: lack of dependence upon opioid receptor activationElizabeth J Rahn, Alexander M Zvonok, Alexandros Makriyannis, et al.
Biology of Sex Differences|March 4, 2014
Sex differences in a mouse model of multiple sclerosis: neuropathic pain behavior in females but not males and protection from neurological deficits during proestrusElizabeth J Rahn, Tommaso Iannitti, Renee R Donahue, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 31, 2008
Selective activation of cannabinoid CB2 receptors suppresses neuropathic nociception induced by treatment with the chemotherapeutic agent paclitaxel in ratsElizabeth J Rahn, Alexander M Zvonok, Ganesh A Thakur, et al.
Pharmacology, Biochemistry, and Behavior|March 9, 2011
Pharmacological characterization of AM1710, a putative cannabinoid CB2 agonist from the cannabilactone class: antinociception without central nervous system side-effectsElizabeth J Rahn, Ganesh A Thakur, Jodi Anne T Wood, et al.
Research in Social & Administrative Pharmacy : RSAP|October 4, 2020
Use of path modeling to inform a clinical decision support application to encourage osteoporosis medication useMichael J Miller, Tzuchen Jou, Maria I Danila, et al.
Pageof 3